About Us

Home > About Histogen > Board

Board of Directors

Stephen Chang, PhD (Vice President, Research and Development)

Stephen ChangAs the Vice President for Research and Development at The New York Stem Cell Foundation, Dr. Stephen Chang has overall responsibility for planning, coordinating, and managing the activities of the research department. In this role, he provides senior leadership in the areas of research and development, oversight of short and long term projects with regulations and policies related to administration and business units, partnerships with industry and other research institutions, and supervision and evaluation of projects.

Gail K. Naughton, Ph.D., CEO, Chairman of the Board

Gail K. NaughtonDr. Gail Naughton founded Histogen, Inc. in 2007, and currently serves as CEO and Chairman of the Board for the Company. She has spent more than 25 years extensively researching the tissue engineering process, holds more than 95 U.S. and foreign patents, and has been extensively published in the field.gnaughton@histogeninc.com

Leonard H. Lavin, Founder & Chairman Emeritus, Alberto-Culver Company

Leonard H. LavinLeonard H. Lavin is the founder, Chairman Emeritus and a director of the Alberto-Culver Company (NYSE: ACV), a $1.4 billion company which manufactures, markets and distributes beauty, personal care and household/ grocery products in over 120 countries. Alberto-Culver's leading global personal care products include Alberto VO5, TRESemme, St. Ives, Nexxus, Soft & Beautiful, Motions and Just For Me and a group of important regional brands.

Susan Baxter, CSUPERB Executive Director

Dr. Susan BaxterDr. Baxter has over twenty years of research and management experience in business, nonprofit and academic settings. Currently she is the Executive Director of the California State University Program for Education and Research in Biotechnology (CSUPERB), a system-wide program that supports biotechnology research, sponsors innovative new curriculum, and serves as a liaison for the CSU and government, educational and industry partners.

Jonathan Jackson

Jonathan Jackson

A few years after completing his degree in Business Management in London, Jonathan Jackson set up his own company to develop commercial real estate in Central Europe. Over the last 20 years he has currently under development and developed more than 6,000,000 sqft of space. Since selling a portfolio of completed assets in early 2007 in one of the largest deals in Central Europe, Mr. Jackson has diversified and invested over $15M in different business sectors, both in the USA and Europe, with great success.

John Rao, President, Secure Medical

John Rao

Mr. Rao's passion for technology spans over 40 years, and he holds a number of patents and patent applications for innovative technologies. In 1999, he founded Tempe-based Secure Medical to bring healthcare services closer to patients through telemedicine, telehealth and telecare applications, and currently serves as CEO for the Company. In addition to Secure Medical, Mr. Rao has owned and operated 14 technology driven companies spanning a variety of industries including retail, wholesale, manufacturing and product development, as well as computer sciences and security driven methodologies.

Brian Satz, Founder, Satz Law Group LLC

Brian Satz

Brian M. Satz is an attorney and founder of Satz Law Group LLC in Fairfield, New Jersey. Mr. Satz has extensive experience representing clients in all aspects of corporate and commercial transactions as well as their day-to-day business matters. In particular, Mr. Satz has advised numerous investors and businesses in the biotech and life sciences industries and has been involved in the financing of many early stage companies. Prior to the founding of Satz Law Group, Mr. Satz spent the vast majority of his career working at large New York City based law firms.

Bernard D. King, M.D., Principal and CEO, Macnas Consulting International, Inc.

Macnas specializes in strategic product development planning and operational execution for pharmaceutical, biotechnology and medical device companies and in due diligence consulting for venture capital, investment, and pharmaceutical firms. Dr. King's breadth and depth of experience are particularly valuable to smaller companies facing significant strategic product development decisions.

Scientific Advisory Board

Neil Sadick, M.D., F.A.A.D, F.A.A.C.S., F.A.C.P., F.A.C.P.h

Dr. Neil SadickA prominent dermatologist and researcher, Neil Sadick holds positions as Clinical Professor of Dermatology at Weill Cornell Medical College and President of the Cosmetic Surgery Foundation, in addition to being the founder of Sadick Dermatology, a leading aesthetic medicine practice in New York. He is board certified in Dermatology, Cosmetic Surgery, Internal Medicine, and Hair Transplantation.

David Easter, M.D., F.A.C.S.

Dr. David EasterDavid Easter is a general surgeon whose passion is education, with special interests in surgical oncology, diseases of the gastrointestinal tract, and laparoscopic surgery. As a recent Director of the Clinical Oncology Programs for the Rebecca and John Moores UCSD Cancer Center, Dr. Easter organized the Cancer Center's clinical and research efforts to provide the finest possible care for cancer patients. He currently serves as Professor of Clinical Surgery at UCSD, and is dedicated to providing the best in surgical care through translating the latest research discoveries into clinical practice.

Craig L. Ziering, D.O., F.A.O.C.D.

Craig L. ZieringDr. Craig L. Ziering is a leading authority in hair transplant surgery, with more than 16 years of specialized experience in hair restoration. In addition to performing over 12,000 hair transplant procedures, he is an author, lecturer, trusted surgeon to physicians, and innovator in the field. As founder and medical director of Ziering Medical, he currently operates hair restoration centers throughout California, Utah and Nevada.

Dale P. DeVore, Ph.D.

Dale P. DeVore

Dale Devore is currently Vice President of Research & Development for BioForm Medical, Inc. Prior to joining BioForm, he was a consultant to several major medical device companies, including three involved in developing dermal filler products. He was previously a member of the Board of Directors and Senior Vice President of Research & Development and the Chief Scientific Officer for Collagenesis, Inc., and inventor/ co-inventor of all of the Company's technologies.

Histogen Inc. is a regenerative medicine company based on the commercialization of products manufactured by newborn human cells.
  • Broad range of markets, which are underserved and expected to grow
  • Rich product portfolio
  • Solutions without the use of embryonic stem cells or animal products
© Histogen Inc., CA 92121